We partly rely on third-party manufacturers (contract manufacturing organizations, or “CMOs”) to manufacture and supply our product candidates for our preclinical and clinical studies
we rely on third parties to manufacture nonclinical and clinical supplies of our product candidates, to store critical components of our product candidates and perform various services related to the…
one or more of our third-party manufacturing vendors may be found on regulatory inspection by the FDA or other comparable foreign regulatory authorities to be noncompliant with cGMP regulations
Reciprocal relationship from KMDA graph: License Application (BLA) of the product, in consideration for a $ million payment from Takeda, which was paid by Takeda and accounted for as income during th…
Reciprocal relationship from LENZ graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ g…
Although we oversee our contract manufacturers, we cannot control the implementation of the manufacturing process by the contract manufacturing partners
we cannot be certain that identifying and establishing relationships for these services would not result in significant delay or increased cost in the development of our product candidates or manufac…
Reciprocal relationship from KMDA graph: ch were received and accounted for as income through December 31, 2021, and for a minimum commitment of Takeda to acquire GLASSIA produced by the Company over…
Reciprocal relationship from LENZ graph: Item 1. Business Overview We are a commercial pharmaceutical company focused on the development and commercialization of innovative therapies to improve visio…
Alvotech Debt Obligations
Instrument
Description
Confidence
Evidence
ALVO-DEBT
Debt stack $1.5B
90%
Market cache reports total debt of $1.5B.
Alvotech Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Alvotech.
Alvotech Ownership
Holder
Name
Confidence
Evidence
ALVO-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 57 tracked holders.